ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
72.83
-0.68 (-0.93%)
Aug 28, 2026, 4:00 PM EDT - Market closed
ANI Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,561 | 1,650 | 1,079 | 1,052 | 656 | 771 | |
Market Cap Growth | -21.72% | 52.89% | 2.58% | 60.42% | -14.98% | 121.46% |
Enterprise Value | 1,810 | 2,010 | 1,583 | 1,175 | 913 | 966 |
Last Close Price | 72.83 | 78.94 | 55.28 | 55.14 | 40.23 | 46.08 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.04 | 23.50 | - | 68.00 | - | - |
Forward PE | 7.74 | 10.03 | 10.72 | 14.04 | 14.79 | 12.86 |
PS Ratio | 1.60 | 1.87 | 1.76 | 2.16 | 2.07 | 3.57 |
PB Ratio | 2.61 | 3.05 | 2.52 | 2.30 | 1.94 | 2.15 |
P/TBV Ratio | 18.39 | - | - | 5.38 | 19.39 | 64.94 |
P/FCF Ratio | 9.02 | 9.63 | 22.59 | 9.56 | - | 1008.43 |
P/OCF Ratio | 8.24 | 8.91 | 16.86 | 8.85 | - | 232.23 |
PEG Ratio | - | 0.40 | 0.40 | 0.40 | 1.11 | 1.02 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.85 | 2.28 | 2.58 | 2.41 | 2.89 | 4.47 |
EV/EBITDA Ratio | 8.64 | 11.50 | 15.58 | 10.75 | 26.93 | 50.64 |
EV/EBIT Ratio | 14.64 | 24.12 | 46.68 | 23.73 | - | - |
EV/FCF Ratio | 10.46 | 11.73 | 33.14 | 10.67 | - | 1263.31 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.05 | 1.16 | 1.46 | 0.62 | 0.85 | 0.80 |
Debt / EBITDA Ratio | 2.93 | 3.52 | 6.14 | 2.61 | 8.26 | 15.06 |
Debt / FCF Ratio | 3.62 | 3.67 | 13.06 | 2.60 | - | 375.65 |
Net Debt / Equity Ratio | 0.42 | 0.62 | 1.10 | 0.14 | 0.71 | 0.52 |
Net Debt / EBITDA Ratio | 1.19 | 1.91 | 4.65 | 0.59 | 7.07 | 9.80 |
Net Debt / FCF Ratio | 1.44 | 1.95 | 9.90 | 0.59 | -5.98 | 244.54 |
Asset Turnover | 0.69 | 0.65 | 0.56 | 0.59 | 0.41 | 0.35 |
Inventory Turnover | 2.75 | 2.44 | 1.91 | 1.68 | 1.48 | 1.41 |
Quick Ratio | 2.30 | 2.07 | 1.92 | 2.63 | 2.15 | 2.61 |
Current Ratio | 2.91 | 2.71 | 2.72 | 3.57 | 3.46 | 3.68 |
Return on Equity (ROE) | 20.46% | 16.16% | -4.18% | 4.72% | -13.74% | -15.37% |
Return on Assets (ROA) | 5.45% | 3.82% | 1.94% | 3.72% | -2.10% | -2.86% |
Return on Invested Capital (ROIC) | 10.96% | 7.67% | 4.76% | 8.51% | -4.58% | -6.04% |
Return on Capital Employed (ROCE) | 10.20% | 7.20% | 3.10% | 6.50% | -3.90% | -4.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.38% | 4.75% | -1.72% | 1.79% | -7.30% | -5.52% |
FCF Yield | 11.08% | 10.39% | 4.43% | 10.46% | -6.11% | 0.10% |
Payout Ratio | - | 1.48% | - | 8.65% | - | - |
Buyback Yield / Dilution | -12.56% | -9.89% | -6.18% | -11.89% | -29.09% | -5.28% |